CYBN•benzinga•
Cybin Announced Partnership With Segal Trials For Phase 3 MDD Program; CYB003 Achieves 71% Depression Remission Over 12 Months In Phase 2 Trial
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 15, 2025 by benzinga